HALOBETASOL PROPIONATE
| Brand name | ULTRAVATE |
|---|---|
| Active ingredient | HALOBETASOL PROPIONATE |
| Strength | 0.05% |
| Dosage form | LOTION |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | November 2015 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8962028 | June 2033 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.